These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35054002)

  • 1. Clinical Characteristics of Macrolide-Refractory
    Choi YJ; Chung EH; Lee E; Kim CH; Lee YJ; Kim HB; Kim BS; Kim HY; Cho Y; Seo JH; Sol IS; Sung M; Song DJ; Ahn YM; Oh HL; Yu J; Jung S; Lee KS; Lee JS; Jang GC; Jang YY; Chung HL; Choi SM; Han MY; Shim JY; Kim JT; Kim CK; Yang HJ; Suh DI
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054002
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of variables associated with prolonged admission duration in children with Mycoplasma pneumoniae pneumonia.
    Sung M; Roh EJ; Lee ES; Lee JY; Kim HB; Ahn Y; Eun BW; Kim JK; Kim HY; Jung SS; Kim M; Kang EK; Yang EA; Lee SJ; Park Y; Seo JH; Lee E; Yang ES; Cho HM; Shin M; Chung HL; Jang YY; Choi BS; Kim H; Jung JA; You ST; Lee MH; Kim JT; Kim BS; Hwang YH; Shim JY; Yang HJ; Han MY; Yew HY; Kim DH; Jeong SO; Whang K; Lee E; Jeon YH; Chung EH
    Clin Respir J; 2022 Nov; 16(11):756-767. PubMed ID: 36205104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clinical manifestations of macrolide resistant
    Lee E; Cho HJ; Hong SJ; Lee J; Sung H; Yu J
    Korean J Pediatr; 2017 May; 60(5):151-157. PubMed ID: 28592978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA.
    Lanata MM; Wang H; Everhart K; Moore-Clingenpeel M; Ramilo O; Leber A
    Emerg Infect Dis; 2021 Jun; 27(6):1588-1597. PubMed ID: 34013867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.
    Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Togashi T; Oba K; Morita K; Nagano N; Nakanishi M; Hara K; Hazama K; Watanabe T; Yamanaka T; Sasaki S; Furuyama H; Shibata M; Shida S; Ishizaka A; Tabata Y; Aoyagi H; Naito H; Yoshioka M; Horino A; Kenri T;
    PLoS One; 2017; 12(3):e0173635. PubMed ID: 28288170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of macrolide resistance in pediatric
    Jiang TT; Sun L; Wang TY; Qi H; Tang H; Wang YC; Han Q; Shi XQ; Bi J; Jiao WW; Shen AD
    Front Cell Infect Microbiol; 2023; 13():1181402. PubMed ID: 37249975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.
    Chen YC; Hsu WY; Chang TH
    Emerg Infect Dis; 2020 Jul; 26(7):1382-1391. PubMed ID: 32568052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases.
    Li P; Wang W; Zhang X; Pan J; Gong L
    Sci Rep; 2024 Mar; 14(1):5632. PubMed ID: 38453960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide Resistance and Its Impacts on M. Pneumoniae Pneumonia in Children: Comparison of Two Recent Epidemics in Korea.
    Kim JH; Kim JY; Yoo CH; Seo WH; Yoo Y; Song DJ; Choung JT
    Allergy Asthma Immunol Res; 2017 Jul; 9(4):340-346. PubMed ID: 28497921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of and the factors associated with macrolide resistance and poor macrolide response in pediatric Mycoplasma pneumoniae infection: A retrospective study.
    Yen MH; Yan DC; Wang CJ; Tsao KC; Huang YC; Cheng SW; Chiu CH; Huang YC; Lin TY
    J Microbiol Immunol Infect; 2023 Jun; 56(3):634-640. PubMed ID: 36737359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.
    Waites KB; Ratliff A; Crabb DM; Xiao L; Qin X; Selvarangan R; Tang YW; Zheng X; Dien Bard J; Hong T; Prichard M; Brooks E; Dallas S; Duffy L; Mixon E; Fowler KB; Atkinson TP
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31484701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Efficacy of Doxycycline for Treatment of Macrolide-Resistant
    Lee H; Choi YY; Sohn YJ; Kim YK; Han MS; Yun KW; Kim K; Park JY; Choi JH; Cho EY; Choi EH
    Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33671151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae.
    Morozumi M; Okada T; Tajima T; Ubukata K; Iwata S
    Int J Antimicrob Agents; 2017 Aug; 50(2):255-257. PubMed ID: 28579455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis.
    Ahn JG; Cho HK; Li D; Choi M; Lee J; Eun BW; Jo DS; Park SE; Choi EH; Yang HJ; Kim KH
    BMC Infect Dis; 2021 Sep; 21(1):1003. PubMed ID: 34563128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of C-reactive protein in response to macrolides in children with macrolide-resistant Mycoplasma pneumoniae pneumonia.
    Seo YH; Kim JS; Seo SC; Seo WH; Yoo Y; Song DJ; Choung JT
    Korean J Pediatr; 2014 Apr; 57(4):186-92. PubMed ID: 24868216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.
    Cheong KN; Chiu SS; Chan BW; To KK; Chan EL; Ho PL
    J Microbiol Immunol Infect; 2016 Feb; 49(1):127-30. PubMed ID: 25556047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Clinical Features of Community-Acquired Pneumonia Caused by Macrolide-Resistant
    Choi JH; Seong GM; Ko Y; Kim YR; Kim C
    Microb Drug Resist; 2019 May; 25(4):577-581. PubMed ID: 30484744
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.
    Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH
    J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide Resistance, Clinical Features, and Cytokine Profiles in Taiwanese Children With
    Wu TH; Wang NM; Liu FC; Pan HH; Huang FL; Fang YP; Chiang TW; Yang YY; Song CS; Wu HC; Lee CY
    Open Forum Infect Dis; 2021 Sep; 8(9):ofab416. PubMed ID: 34557557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology, clinical characteristics, and macrolide susceptibility of Mycoplasma pneumoniae pneumonia in children in Southern Taiwan, 2019-2020.
    Kuo CY; Tsai WC; Lee HF; Ho TS; Huang LM; Shen CF; Liu CC;
    J Microbiol Immunol Infect; 2022 Aug; 55(4):611-619. PubMed ID: 34688576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.